| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30005504 | HIV | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS30026671 | HIV | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS30026672 | HIV | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS20000916 | HPV | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS20046556 | HPV | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS44012771 | HTLV-1 | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS44010815 | HTLV-1 | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
| TVIS44036114 | HTLV-1 | ENSG00000143799.14 | protein_coding | PARP1 | No | Yes | 142 | P09874 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PARP1 |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0001717 |
| UniProt ID | P09874 |
| Regulation Type | |
| PubMed IDs | 25549802 |
| Citations | Bossak K, Goch W, Piatek K, Fraczyk T, Poznanski J, Bonna A, Keil C, Hartwig A, Bal W: Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. Chem Res Toxicol. 2015 Feb 16;28(2):191-201. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
